Cereber Pharmaceuticals Private Limited
About Cereber Pharmaceuticals Private Limited
Data last updated:
Cereber Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC313428. Its GSTIN is 27AAHCC7264N1Z2 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shaikh Abed Hamed and Firdose Shamshir Ali Syed Syed.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 76 – 2st Colony Hatte Singpura, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.35 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹7.3 Lakh (net margin 5.4%) and EBITDA of ₹10.8 Lakh (EBITDA margin 8%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years.
Company details
Contact details
Cereber Pharmaceuticals Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 76 – 2st Colony Hatte Singpura, Aurangabad, Maharashtra, India – 431001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Cereber Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Cereber Pharmaceuticals Private Limited
FY 2025 filings availableCereber Pharmaceuticals Private Limited reported revenue of ₹1.35 Cr (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 21% over three years, including a 8% fall in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.8 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.3 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8% | ||||
| Net Profit Margin | 5.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cereber Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cereber Pharmaceuticals Private Limited
Cereber Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shaikh Abed Hamed | Director | 04 Sep 2018 | 8 Years 1 Months | Current |
| Firdose Shamshir Ali Syed Syed | Director | 04 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Cereber Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cereber Pharmaceuticals Private Limitedthis company | ₹1.35 Cr (FY 2025) | ₹7.3 Lakh | 5.4% | -8.0% | Aurangabad, Maharashtra, India | |
| Upform Pharmaceuticals Private Limited | ₹1.35 Cr (FY 2024) | 331.0% | Delhi, India | |||
| Maheshwar Distributors Private Limited | ₹1.35 Cr (FY 2025) | -79.0% | Mumbai, Maharashtra, India | |||
| Dowell Life Science Private Limited | ₹1.35 Cr (FY 2024) | 4.0% | Ahmedabad, Gujarat, India | |||
| Mkurizon Healthcare Private Limited | ₹1.35 Cr (FY 2024) | 30.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Cereber Pharmaceuticals Private Limited, buy the company report.
Auditor
Cereber Pharmaceuticals Private Limited is audited by HAKEEM AND ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HAKEEM AND ASSOCIATES | FY 2019 | 137304W |
Shareholding
The shareholding of Cereber Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Cereber Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cereber Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cereber Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cereber Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCC7264N1Z2 | Maharashtra | Active | 12 Oct 2018 |
To see the full GST registrations and return filing status of Cereber Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cereber Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Firdose Shamshir Ali Syed Syed was appointed as Director on 04 Sep 2018.
Frequently asked questions
Cereber Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 September 2018 (8+ years old) and is registered under CIN U74999MH2018PTC313428.
Cereber Pharmaceuticals has 2 current directors:
- Shaikh Abed Hamed - Director
- Firdose Shamshir Ali Syed Syed - Director
The latest financial statements of Cereber Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Cereber Pharmaceuticals is 27AAHCC7264N1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of Cereber Pharmaceuticals is U74999MH2018PTC313428. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cereber Pharmaceuticals was incorporated on 04 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Cereber Pharmaceuticals by revenue are Upform Pharmaceuticals Private Limited, Maheshwar Distributors Private Limited, Dowell Life Science Private Limited, Mkurizon Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (retail trading).
Firdose Shamshir Ali Syed Syed was appointed as Director on 04 Sep 2018. Shaikh Abed Hamed was appointed as Director on 04 Sep 2018.
The registered office of Cereber Pharmaceuticals is at Plot No 76 – 2st Colony Hatte Singpura, Aurangabad, Maharashtra, India – 431001.
Cereber Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Cereber Pharmaceuticals can be reached at its registered office: Plot No 76 – 2st Colony Hatte Singpura, Aurangabad, Maharashtra, India – 431001.